The clinical study will evaluate the feasibility and acceptability of a culturally tailored behavioral intervention to improve uptake of pre-exposure prophylaxis for HIV prevention among at-risk Latino men who have sex with men.
The clinical study will evaluate the feasibility and acceptability of a brief small group and peer navigation behavioral intervention to improve uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among at-risk Latino men who have sex with men. The brief intervention consists of 4 small group sessions with concurrent peer navigation and counseling. Study participants will be randomized to either an intervention or control condition. Participants in the control condition will receive usual care for PrEP promotion (i.e., referral to PrEP services). The study will determine the feasibility and acceptability of the intervention among Latino men who have sex with men and assess the preliminary impact of the intervention compared to control condition in facilitating PrEP uptake.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
80
Participants will receive an Information, Motivation, and Behavioral skills model PrEP intervention tailored for mixed immigrant status Latino men who have sex with men
Participants will be offered PrEP navigation services as part of usual care at the study site.
Bienestar Human Services
Los Angeles, California, United States
RECRUITINGPrEP initiation
We will assess PrEP uptake using evidence of a prescription for Truvada® or Descovy® (participant shows us their prescription bottle in person or via a text photo).
Time frame: assessed at 1-month follow-up
PrEP initiation
We will assess PrEP uptake using evidence of a prescription for Truvada® or Descovy® (participant shows us their prescription bottle in person or via a text photo).
Time frame: assessed at 3-month follow-up
PrEP adherence single measure
We will assess adherence to the PrEP medication using a single-item self-rating adherence measure.
Time frame: assessed at 1-month follow-up
PrEP adherence single measure
We will assess adherence to the PrEP medication using a single-item self-rating adherence measure.
Time frame: assessed at 3-month follow-up
PrEP adherence urine sample
We will assess adherence to the PrEP medication by analyzing participants' urine sample to determine the presence of the medication tenofovir, a key medication in the PrEP medication.
Time frame: assessed at 1-month follow-up
PrEP adherence urine sample
We will assess adherence to the PrEP medication by analyzing participants' urine sample to determine the presence of the medication tenofovir, a key medication in the PrEP medication.
Time frame: assessed at 3-month follow-up
Changes in Readiness to Adopt PrEP
We will assess changes in readiness to adopt PrEP using the PrEP Transtheoretical Stages of Change Model measure (pre-contemplation, contemplation, preparation, action \& initiation, and maintenance).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: assessed at 1-month follow-up
Changes in Readiness to Adopt PrEP
We will assess changes in readiness to adopt PrEP using the PrEP Transtheoretical Stages of Change Model measure (pre-contemplation, contemplation, preparation, action \& initiation, and maintenance).
Time frame: assessed at 3-month follow-up